See today's BioWorld
To read the full story, subscribe or sign in.

South Korea's Celltrion builds Hong Kong biosimilar JV Vcell aimed at Chinese market

July 22, 2019
By Jihyun Kim
HONG KONG – Celltrion Inc., of South Korea, and Hong Kong-based conglomerate Nan Fung Group Holdings Ltd. said they have built a joint venture named Vcell Healthcare Ltd., geared toward the Chinese market. 
BioWorld Deals and M&A Joint venture Biosimilar